Fundz

Aurum Biosciences Raise £730k in Fresh Investment

PRIVATEJan 31, 2024

Amount Raised

£730,000

Round Type

Seed

Biotechnology Research

Investors

Tricapital Business Angel SyndicateScottish EnterpriseInno Scot HealthDr Celestine Santosh

Description

Aurum Biosciences has raised almost £730,000 in the first tranche of a new round of equity funding to further develop its therapeutic and diagnostic technology.

Quick answer

Aurum Biosciences raised £730,000 in a Seed round, dated January 31, 2024. Investors: Tricapital Business Angel Syndicate, Scottish Enterprise, Inno Scot Health and Dr Celestine Santosh.

How much did Aurum Biosciences raise?
Aurum Biosciences raised £730,000 in a Seed round on January 31, 2024.
Who invested in Aurum Biosciences?
Tricapital Business Angel Syndicate, Scottish Enterprise, Inno Scot Health and Dr Celestine Santosh are named as investors in this round.
What does Aurum Biosciences do?
Aurum Biosciences Ltd is a clinical stage biopharmaceutical company developing novel oxygen carriers for use as therapeutics and diagnostics, initially for Acute Ischaemic Stroke (AIS).
Who are the decision-makers at Aurum Biosciences?
Fundz holds 1 contact at Aurum Biosciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology Research around the same time

Companies in the same sectors as Aurum Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Baseimmune raised $11M (Series A) on February 26, 2024.
  • eFeed raised $10M (Seed) on February 21, 2024.
  • VRG Therapeutics raised $15M (Series B) on February 20, 2024.
  • Colipi raised $1.9M (Seed) on February 19, 2024.
  • FreezeM raised $14M (Series A) on February 15, 2024.
  • SingleTimeMicroneedles raised an undisclosed amount (Pre-Seed) on February 14, 2024.

Who to call at Aurum Biosciences, and when

A new round usually means Aurum Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aurum Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aurum Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aurum Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aurum Biosciences

About

Aurum Biosciences Ltd is a clinical stage biopharmaceutical company developing novel oxygen carriers for use as therapeutics and diagnostics, initially for Acute Ischaemic Stroke (AIS). Follow-on indications include heart disease, oncology, inflammatory conditions, spinal cord injury, and dementia. Preclinical development has been completed in the lead indication (AIS) and approval has been granted to initiate clinical studies in acute stroke patients. Concurrently, Aurum is pursuing opportunities to develop its pipeline indications with a focus on inflammatory conditions and oncology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aurum Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Aurum Biosciences's next move

See what Strategic adds

Aurum Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.